UnknownNot applicableNCT04663412

Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer

Studying Vulvar carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Azienda Ospedaliera per l'Emergenza Canizzaro
Principal Investigator
Paolo Scollo, Prof.
A.O.E. Cannizzaro
Intervention
Sentinel lymph node mapping with indocyanine green fluorescence imaging in vulvar cancer (FIGO Stage IB)(other)
Enrollment
2 target
Eligibility
20-100 years · FEMALE
Timeline
2020 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04663412 on ClinicalTrials.gov

Other trials for Vulvar carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Vulvar carcinoma →

← Back to all trials